Phase I clinical trial of donor T-helper Type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant

Autor: Fowler, D., Hou, J., Foley, J., Hakim, F., Odom, J., Castro, K., Carter, C., Read, E., Gea-Banacloche, J., Kasten-Sportes, C., Kwak, L., Wilson, W., Levine, B., June, C., Gress, R., Bishop, M.
Zdroj: In Cytotherapy September 2002 4(5):429-430
Databáze: ScienceDirect